2022
DOI: 10.1007/s12035-022-02864-w
|View full text |Cite
|
Sign up to set email alerts
|

Systemic, Intrathecal, and Intracerebroventricular Antihyperalgesic Effects of the Calcium Channel Blocker CTK 01512–2 Toxin in Persistent Pain Models

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 98 publications
0
3
0
Order By: Relevance
“…These peptides have been evaluated in pre-clinical models and demonstrated interesting therapeutic efficacy in reverting or preventing conditions for which treatments are limited or unavailable. For example, ω-Pn2a and ω-Pn4a showed efficacy in treating painful neuropathies such as fibromyalgia and chronic post-ischemia pain, respectively ( Pedron et al, 2021 ; Cavalli et al, 2022 ), ω-Pn4a also improved motor movement and neuroprotection in Huntington’s disease ( Joviano-Santos et al, 2022 ). The engineered peptide PnPP-19 derived from the venom peptide δ-Pn2a was efficacious in treating glaucoma ( da Silva et al, 2020 ) and erectile dysfunction ( Nunes da Silva et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These peptides have been evaluated in pre-clinical models and demonstrated interesting therapeutic efficacy in reverting or preventing conditions for which treatments are limited or unavailable. For example, ω-Pn2a and ω-Pn4a showed efficacy in treating painful neuropathies such as fibromyalgia and chronic post-ischemia pain, respectively ( Pedron et al, 2021 ; Cavalli et al, 2022 ), ω-Pn4a also improved motor movement and neuroprotection in Huntington’s disease ( Joviano-Santos et al, 2022 ). The engineered peptide PnPP-19 derived from the venom peptide δ-Pn2a was efficacious in treating glaucoma ( da Silva et al, 2020 ) and erectile dysfunction ( Nunes da Silva et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…This has been demonstrated for numerous spider venoms ( Smith et al, 2015 ; Cardoso and Lewis, 2018 , 2019 ), including the venom of the infamous South American ctenid spider Phoneutria nigriventer , often referred as Brazilian wandering spider, banana spider or “armed” spider ( Peigneur et al, 2018 ). Besides its clinical relevance due to frequent envenomation cases in Brazil, with approximately 4,000 cases per year ( Isbister and Fan, 2011 ; Gewehr et al, 2013 ), P. nigriventer venom contains peptides that have therapeutic effects in a range of disease models including chronic pain ( Pedron et al, 2021 ; Cavalli et al, 2022 ), Huntington’s disease ( Joviano-Santos et al, 2022 ), glaucoma ( da Silva et al, 2020 ) and erectile dysfunction ( Nunes da Silva et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…This has been demonstrated for numerous spider venoms (Smith et al, 2015;Cardoso and Lewis, 2018;2019), including the venom of the infamous South American ctenid spider Phoneutria nigriventer , often referred as Brazilian wandering spider, banana spider or “armed” spider (Peigneur et al, 2018). Besides its clinical relevance due to frequent envenomation cases in Brazil, with approximately 4,000 cases per year (Isbister and Fan, 2011;Gewehr et al, 2013), P. nigriventer venom contains peptides that have therapeutic effects in a range of disease models including chronic pain (Pedron et al, 2021;Cavalli et al, 2022), Huntington’s disease (Joviano-Santos et al, 2022), glaucoma (da Silva et al, 2020) and erectile dysfunction (Nunes da Silva et al, 2019).…”
Section: Introductionmentioning
confidence: 99%